Crixivan GlaxoWellcome Bristol-Meyer Squibb Company
Time
Monday
February 1, 1999
Tuesday
February 2, 1999
Wednesday
February 3, 1999
Thursday
February 4, 1999

2-4pm

Session 7.
Metabolic Complications of Antiviral Therapy: Clinical Implications

Session 8.
Interventions in Perinatal Transmission

Session 9.
Chemokine Receptors and Genetic Markers in HIV Disease Pathogenesis

Session 38.
HIV-Related Neoplasia: Advances and Controversies

Session 39.
Accessory Gene Functions

Session 40.
Live Vaccine Vectors

Session 65.
Update on HIV Epidemiology and Prevention

Session 66.
Antiretroviral Resistance: Basic Mechanisms and Clinical Issues

Session 67.
Structure/Assembly

8–10 am
Special Symposium

Immune Reconstitution and Clinical Implications

 

 

© 6th Conference on Retroviruses and Opportunistic Infections,
Foundation for Retrovirology and Human Health

This site designed and maintained by:
© Medical Consumer Media. All Rights Reserved.
For inquiries, contact: retroinfo@medcm.com

The broadcasts of selected invited sessions from the 6th Conference on Retroviruses and Opportunistic Infections are for individual, non-commercial use only. No portion of this site (including speakers' audiotrack, slides, and abstracts) may be copied, reproduced, or rebroadcast without the express advanced written permission of the speaker(s) and the Conference Secretariat.